Harmony Biosciences racks up $270 mln
Plymouth Meeting, Pennsylvania-based Harmony Biosciences LLC, a biopharmaceutical company, has closed $270 million in funding. The investors included Valor Equity Partners, Fidelity Management & Research Company, HBM Healthcare Investments, Vivo Capital, venBio Partners, Novo Holdings and Nan Fung Life Sciences.
9 October 2017•1 min read
